The choice of the triazine-based TTA-DFP-nCOF was primarily based on its high stability under harsh conditions including acidic environments.47,48 The unique features of this delivery method are its high insulin-loading capacity (∼65 wt%), biocompatibility, insulin protection under harsh conditions and hyperglycemia-induced drug release. Here, INS is linked to Hyperglycemia.